Elevated myc expression and c-myc amplification in spontaneously occurring B lymphoid cell lines by unknown
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Recently, a minor subpopulation of murine B lymphocytes has been distin-
le inimmune physiologyand disease . These cells, initially
novel surface elevation of the Ly-1 antigen, are most
geny, and have a restricted tissue distribution and
precursor origin (1) . They are the predominant source of autoantibody produc-
tion in normal and autoimmune mouse strains (2, 3), and provide a novel
stimulatory influence to the production of antiallotypic and antiidiotypic anti-
bodies (4, 5) . The Ly-I + B cell phenotype accounts for most spontaneousmurine
B cell lymphomas and leukemias (6, 7) . In man, B lymphocytes expressing CD5,
the human Ly-1 homologue, are the predominant phenotype in chronic lympho-
cytic leukemia (8), and are elevated early in bone marrow transplantation (9),
and possibly in certain autoimmune diseases (10, 11) .
We have reported a simple cell culture strategy that allows the exclusive
outgrowth of long-term Ly-I' B cell lines (12, 13) . T cell-depleted splenic
lymphocyte cultures, maintained at high cell density for 2 wk in the absence of
nominal lymphocytotrophic hormones or stimuli, enter a period of crisis . How-
ever, by 3-4 wk, Ly-1 ' B lymphoblasts are detectable ; within an additional 2-3
wk, stable, robustly proliferating cell lines may be established . These cell lines,
-1 cells, have been serially passaged for >3 yr, and hence have an
growth phenotype . In addition, they are clonable in soft agar, and at
dilution at high cloning efficiency (>50%) . However, they are not
tumorigenic after inoculation into syngeneic animals .
The spontaneous occurrence and sustained in vitro growth ofB Ly-1 cells led
us to assess their expression of c-myc, a protooncogene with elevated transcription
initial phase ofB cell mitogenesis (14, 15)and deregulated expression
cell neoplasms (16, 17, reviewed in 18) . Here we report high steady-
state levels of c-myc mRNA in B Ly-1 cells, which correlates with amplification
of the c-myc locus .
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Materials and Methods
Cell Lines.
￿
B Ly-1 cell lines were established according to the previously established
method (13) from C3H/HeJ, MRL/++, and A/J mice, and cloned by two or more serial
limiting-dilution cultures in the absence offeeder cells. 70Z/3 is a pre-Bcell line established
from a methyl nitrosourea-induced tumor in thymectomized (DBAx C57BC/6)F, mouse
(19). WEHI 231, WEHI 279, and 74.10 (a tissue culture-adapted subclone of CH 1) are
surface IgM+ B lymphocyte cell lines described previously (6, 11). All cell lines were
cultured in RPMI 1640, supplemented with 10% heat-inactivated FCS (Hyclone Labora-
tories, Logan, UT), 50,M 2-ME, and penicillin/streptomycin .
Purification and Analysis of RNA andDNA.
￿
Cytoplasmic RNA was prepared from the
postnuclear fraction of NP-40 cell lysates (20). RNA (15 jug/lane) was electrophoresed on
1 .2% formaldehyde agarose gels (21), and stained with ethidium bromide to visualize
ribosomal RNA bands for use as internal molecular mass standards. Gels were blotted by
capillary transfer to Zetabind nylon filters (AMF-Cuno, Meriden, CT) following the
commercial protocol.
Genomic DNA was prepared from the nuclear fraction of NP-40 lysates by standard
methods (21). After exhaustive- restriction enzyme digestion, DNA (12 Fag/lane) was
electrophoresed on 0.8% agarose gels in TBE buffer (0.089 M Tris, 0.89 M boric acid,
0.002 M EDTA), including 0.5 kg/ml ethidium bromide. Eco RI/Hind III-digested a
DNA (Boehringer-Mannheim Biochemicals, Indianapolis, IN) served as molecular mass
standard. Gels were photographed and blotted to Zetabind nylon filters using the com-
mercial modification of the method of Southern.
Blots were hybridized with nick-translated plasmid fragments in 5x SSCPE (0.75 M
NaCl, 0.075 M sodium citrate, 0.0375 M sodium phosphate, 0.005 M EDTA, pH 7.4),
lx Denhardt's solution, 50% formamide, 0.1 mg/ml herring sperm DNA, for 36 h at
42°C. Blots were washed at 65°C in 2x SSC (0.3 M NaCI, 0.03 M sodium citrate, pH
7 .0), 0.1 % SDS and autoradiographed using Kodak XAR film at -70'C with an intensi-
fying screen. In some cases, autoradiograms were analyzed by densitometry using a LKB
Ultrascan with a 2220 recording integrator (LKB-Produktor AB, Bromma, Sweden); for
this purpose, exposure times were chosen giving a linear range of film development (0.2-
0.6 OD).
Recombinant DNA.
￿
pmyc-26, a murine c-myc genomic clone (30) was used to prepare a
2 .0 kb Xba I-Hind III fragment for use as a myc probe. pß2m, a gift from J. Seidman,
consists of a 4 kb Hind III genomic segment (including second and third exons) of the
murine ß2 microglobulin gene subcloned into pBR322 (31); a Sac I/Kpn I subfragment
was used as specific ß2 microglobulin probe. Probes were nick-translated with a-[s2P]ATP
(New England Nuclear, Boston, MA) for blot hybridization. All restriction enzymes were
purchased from New England Biolabs, Beverley, MA.
Results
The expression of myc transcripts was analyzed by Northern blots of cyto-
plasmic RNA. 750-13, a cloned B Ly-1 cell line, derived from C3H/HeJ mice,
expressed a 2.3 kb myc RNA corresponding in size to the conventional murine
c-myc transcript. The level of expression, however, when compared with the
murine pre-13 cell line 70Z/3, was strikingly elevated (Fig. 1 a). Similar results
were also observed in independent clones of B Ly-1 cell lines derived from two
other mouse strains (AJ and MRL; Fig. 1 b).
To assess the degree of myc overexpression, Northern blots were prepared
using RNA from a number of B Ly-1 clones and other B lymphocyte cell lines.
Integrative densitometry was then carried out on blots which were sequentially
hybridized with probes for myc and 02 microglobulin (chosen as an independent,
constitutively expressed RNA). The resulting values of myc transcript expression1190
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FIGURE 1 .
￿
Elevated c-myc RNA transcripts in B Ly-1 cells .
Formaldehyde-denatured cytoplasmic RNA was electropho-
resed, Northern transferred to nitrocellulose, and hybridized
with a nick-translated myc probe . (a) 70Z/3, 750-13 ; (b)
70Z/3, C3H/HeJ (670-6), A/J (AJ 12), MRL (MRL 37) .
in B Ly-1 cells, as normalized to the levels of the 02 microglobulin transcript,
ranged up to 45-fold above the level observed in 70Z/3 RNA (Table I) .
The genomic c-myc configuration was evaluated by Southern blot analysis of
DNA from 750-13 as compared with syngeneic C3H/HeJ liver DNA (Fig . 2).
Digestion of genomic DNA from 750-13 with four restriction endonucleases
revealed a pattern of myc hybridization indistinguishable from that of the liver
DNA, indicating no DNA rearrangement within the c-myc transcription unit.
The intensity of the hybridization signal, however, (using ,Q2 microglobulin as a
single copy gene internal standard) revealed that the c-myc band in the 750-13
was amplified 5-10-fold (Fig . 2) . Independently derived cell lines from another
two mouse strains also exhibited amplification of the c-myc locus (Fig . 3) . Pro-
longed tissue culture passage (6-9 mo) correlated, in the one C3H/HeJ cell line
examined, with increased c-myc amplification (data not shown) .
Discussion
Quantitative analysis of cytoplasmic RNA from B Ly-1 cells has revealed a
substantially elevated steady-state level of c-mycRNA. Genomic rearrangements
of the c-myc locus were notevident within the transcription unit, but a 2-10-fold
c-myc amplification was observed .
Constitutively elevated myc RNA expression is a characteristic feature in
lymphoid neoplasia . The mechanisms for this altered regulation include c-myc
translocation to the immunoglobulin locus (reviewed in 22-24), and proviral
insertion near the myclocus (25-28). The absence of short-range c-myc rearrange-
ments (Fig . 1) argues against the role of such events in B Ly-1 cells. However B
Ly-1 cytogenetic abnormalities, including lack of a normal chromosome 6 (u
locus) and 15 (myc locus), leave open the possibility that a more distant rearrange-CITRI ET AL .
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TABLE I
Levels ofmycRNA inB Ly-1 Compared with Other
Lymphoid Cell Lines
Cytoplasmic RNA from cloned cell lines derived from the three mouse
strains denoted, and from four other B cell lines were electrophoresed in
agarose, Northern transferred, and hybridized sequentially with probes
for myc and 92 microglobulin . Band intensities were quantitated by inte-
grative densitometry, and the level of myc expression was calculated by
normalizing myc integration values with the corresponding ,B2 microglob-
ulin value. Normalized results are tabulated in arbitrary integration units
relative to 70Z/3 .
FIGURE 2 .
￿
Amplification of the
c-myc DNA segment . (a) Liver
(left) and 750-13 (right) DNA
were digested with the indicated
restriction enzymes, then electro-
phoresed, Southern transferred
and hybridized with a nick-trans-
lated myc probe . (b) High-molec-
ular-massDNA was digested with
Eco RI, electrophoresed, South-
ern transferred to nitrocellulose,
and hybridized with nick-trans-
lated probes for mycand 142 micro-
globulin (f2m) . Left,C3H/Hej
liver ; right, 750-13 .
ment may have occurred, with long-range effects on myc transcription (cytoge-
netic data not shown) . Such events may also account for the lack of a linear
correlation between the moderate degree of myc amplification and the remarka-
ble elevation of c-myc expression in the B Ly-1 cells.
It is striking that all of the spontaneously immortalized lymphocytes that are
obtained in these spleen cultures are both Ly-l+ (1, 13) and have an amplified
Strain B cell line Band intensity
70Z/3 1 .0
WEHI 279 1 .5
CHI 2.2
WEHI 231 5.5
BLy-I cell lines
A/J AJ7 45.0
AJ9 18.0
AJ12 20.0
AJ 13 15.0
MRL/++ MRL17 26.2
MRL37 18.8
C3H/Hej 670-6 13.8
750-13 31 .21192
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FIGURE 3 .
￿
Amplification of the c-myc in cells derived from MRL
and A/J mouse strains. Liver (left) and cloned B Ly-1 cell lines
(right) derived from MRL/++ and A/J were analyzed for the level
of c-myc amplification as described in Fig. 2a .
and highly expressed c-myc locus . It is possible thus that the Ly-1+ cells have c-
myc loci that are in a state that may be readily amplified. Another possibility is
that the physiological levels of c-myc expression in these cells is high so that even
moderate amplification of the locus contributes the extra expression needed to
pass the threshold of immortalization . Finally, it is possible that the Ly-1+ B
lymphocytes may be the target of a yet-unidentified transforming agent, analo-
gous to the unique sensitivity of CR2+ human B lymphocytes to EBV transfor-
mation . Analysis of these possibilities may shed light on the peculiar malignant
potential of Ly-l+ B cells in the mouse and on the prevalence of CD-5+ cells in
human chronic lymphocytic leukemia .
Summary
Recently, a minor subpopulation of murine B lymphocytes, Ly-1+B cells, has
been distinguished by its unique ontogeny, tissue distribution, and prominencein certain autoimmune and neoplastic B cell diseases. We have previously de-
scribed a simple murine spleen culture system that results in the spontaneous
and exclusive outgrowth of long-term Ly-1' B cell lines (B Ly-1 cells). Here, we
report that the immortal growth property of B Ly-1 cells correlates with a 10-
45-fold elevation of steady-state myc RNA and 2-10-fold amplification of the
c-myc locus. While c-myc amplification has been observed in malignant cell lines
derived from several tissues of origin, its occurrence in lymphoid cells has not
been previously reported. The consistent c-myc amplification in B Ly-1 cells may
reflect a unique state of this locus in the Ly-1' B lymphocyte lineage, and
contribute to the spontaneous immortalization of this B cell population in vitro,
and its apparent predilection for malignant transformation in vivo.
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